@entity1653 are the second most common primary @entity1313 . Surgical resection is the preferred treatment for easily accessible @entity5 that can be safely removed. However, many @entity5 arise deep within the skull base making complete surgical resection difficult or impossible. Stereotactic radiosurgery is a highly effective alternative to surgical resection that has been used as a primary therapy for @entity1653 as well as an adjuvant treatment for residual or recurrent @entity5 . The 5-year @entity5 control rates for stereotactic radiosurgery are equivalent to gross-total resection with lower morbidity than surgery, especially for skull base lesions. Additionally, adjuvant treatment of subtotally resected @entity5 results in @entity5 control rates equivalent to gross-total resection. Stereotactic radiosurgery has been used extensively for the treatment of small and medium sized skull base @entity1653 . This technique has also been applied to large @entity1653 and @entity5 such as @entity1653 and @entity1653 . However, multiple studies demonstrate that @entity5 control is decreased for superficial lesions and with increasing @entity5 size. In addition, radiation @entity137 increases with increasing @entity5 size and superficial location. Based on a thorough review of the literature, stereotactic radiosurgery should be considered the primary treatment for skull base @entity1653 with high surgical risk and in cases of superficial @entity1653 where surgery is contraindicated.

Stereotactic radiosurgery for XXXX .

@entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'superficial tumors', 'tumors'] @entity1653 :: ('MESH:D008579', 'Disease') :: ['Meningiomas', 'parasagittal meningiomas', 'convexity', 'benign meningiomas', 'meningiomas'] @entity137 :: ('MESH:D064420', 'Disease') :: ['toxicity'] @entity1313 :: ('MESH:D001932', 'Disease') :: ['tumor of the brain']
@entity1653 :: (MESH:D008579,Disease) :: ['benign meningiomas']
